NCT02881346View on ClinicalTrials.gov

Efficacy and Tolerability of Enstilar® in Daily Practice

CompletedOBSERVATIONAL

Enrollment

410

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions

Plaque Psoriasis

Interventions

DRUG

Enstilar®

Once daily application of cutaneous foam to plaques on body and/or extremities

Trial Locations (1)

Unknown

Clinic for Dermatology, Venereology and Allergy, University Clinic Schleswig-Holstein, Kiel

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LEO Pharma

INDUSTRY

NCT02881346 - Efficacy and Tolerability of Enstilar® in Daily Practice | Biotech Hunter | Biotech Hunter